Friday, April 29, 2022

Immunisation Panel Approves Covovax Vaccine For 12-17 Age Group: Report

National Technical Advisory Group on Immunisation (NTAGI) on Friday approved Serum Institute of India's Covovax COVID-19 vaccine for the age group 12-17, said sources.
at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

T20 World Cup Controversy LIVE: Scotland 'Ready' To Replace Bangladesh

Bangladesh T20 World Cup Participation Controversy LIVE : Bangladesh's participation in the T20 World Cup 2026 in India is up in the air...